Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology.

A new study presented at COMy 2025 reveals that patients with amyloid light-chain amyloidosis still face significant delays ...

What: Erlanger Trauma Services will host its annual Trauma Symposium at the Chattanooga Convention Center on Thursday, May 22 ...

The Chattanooga Heart Institute at CHI Memorial announced the opening a new center aimed at detecting and treating an often ...

The initial finding was the start of a harrowing months-long ordeal to figure out what the mass was, including a biopsy that ...

ABSTRACT: Cardiac amyloidosis (CA) is a progressive and life-threatening manifestation of systemic amyloidosis characterized by extracellular deposition of insoluble amyloid fibrils in the myocardium.

Quest Diagnostics has introduced a new blood test aimed at assisting physicians in confirming amyloid brain pathology related to Alzheimer's disease in individuals with mild cognitive impairment ...

Cardiac amyloidosis is significantly underdiagnosed due to low ... By targeting the disease-causing pathology in systemic amyloidosis diseases, PAR therapeutics have the potential to treat and reverse ...

“That’s when the doctor mentioned to me there might be a genetic defect that affects 1 out of 25 African Americans called amyloidosis.” A paper in the Journal of Cardiac Failure notes that 1 ...

Amyloidosis is a group of conditions that cause an abnormal protein called amyloid to build up in the body. Treatment depends on the type of amyloidosis but may include medications and organ ...